Neimeth International Pharmaceuticals plc announced earnings results for the first quarter ended December 31, 2018. For the first quarter, the company announced sales was NGN 227.068 million compared to NGN 394.298 million a year ago. Operating loss was NGN 119.301 million compared to operating Income of NGN 29.957 million a year ago. Net loss was NGN 139.161 million compared to net income of NGN 13.553 million a year ago. Basic loss per share was NGN 0.08 compared to basic earnings per share of NGN 0.01 a year ago.